HomeCompareHPTN vs PLD

HPTN vs PLD: Dividend Comparison 2026

HPTN yields 500000.00% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HPTN wins by $4.663521010693878e+33M in total portfolio value
10 years
HPTN
HPTN
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full HPTN calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — HPTN vs PLD

📍 HPTN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHPTNPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HPTN + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HPTN pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HPTN
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, HPTN beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HPTN + PLD for your $10,000?

HPTN: 50%PLD: 50%
100% PLD50/50100% HPTN
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

HPTN
No analyst data
Altman Z
-11.6
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HPTN buys
0
PLD buys
0
No recent congressional trades found for HPTN or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHPTNPLD
Forward yield500000.00%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$4.663521010693878e+33M$5.91M
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$4,750,725.19
Total dividends collected$4.6634009849658873e+33M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: HPTN vs PLD ($10,000, DRIP)

YearHPTN PortfolioHPTN Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,241$540.96+$50.00MHPTN
2$233,748,371,262$233,694,859,813.08$13,019$991.13+$233748.36MHPTN
3$1,021,074,511,412,696$1,020,824,400,655,446.10$15,801$1,870.97+$1021074511.40MHPTN
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$20,609$3,701.21+$4168597328794.93MHPTN
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$29,919$7,867.97+$15905475114600664.00MHPTN
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$50,631$18,617.74+$56718938532531060736.00MHPTN
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$105,528$51,352.20+$1.8903180743562385e+23MHPTN
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$287,364$174,449.42+$5.8879981047651824e+26MHPTN
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$1,081,760$774,280.77+$1.7140642681147225e+30MHPTN
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$5,908,209$4,750,725.19+$4.663521010693878e+33MHPTN

HPTN vs PLD: Complete Analysis 2026

HPTNStock

Red Eye Guys Ltd., through its subsidiaries, develops and manufactures Biologix Hair Therapy System, a compound and delivery system to treat follicle nutrient deficiency syndrome (FNDS). Its Biologix Hair Therapy System includes Biologix Revive, a hair formula that is administered as a series of shallow injections using a needle targeting the follicles starved by FNDS. Its solution is used to treat reverse and avert FNDS, and alopecia areata. The company was formerly known as Biologix Hair, Inc. and changed its name to Red Eye Guys Ltd. in April 2014. The company is based in Toronto, Canada with subsidiaries in Barbados and Panama.

Full HPTN Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this HPTN vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HPTN vs SCHDHPTN vs JEPIHPTN vs OHPTN vs KOHPTN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.